Daniel S. Pratt

5.3k total citations · 2 hit papers
55 papers, 2.8k citations indexed

About

Daniel S. Pratt is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Daniel S. Pratt has authored 55 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hepatology, 25 papers in Surgery and 21 papers in Epidemiology. Recurrent topics in Daniel S. Pratt's work include Liver Diseases and Immunity (21 papers), Liver Disease Diagnosis and Treatment (21 papers) and Liver Disease and Transplantation (12 papers). Daniel S. Pratt is often cited by papers focused on Liver Diseases and Immunity (21 papers), Liver Disease Diagnosis and Treatment (21 papers) and Liver Disease and Transplantation (12 papers). Daniel S. Pratt collaborates with scholars based in United States, United Kingdom and Germany. Daniel S. Pratt's co-authors include Marshall M. Kaplan, Richard B. Freeman, Gregory Y. Lauwers, John B. Wong, Joseph Misdraji, Patrick Yachimski, Raymond T. Chung, Raymond T. Chung, Oren K. Fix and Elizabeth C. Verna and has published in prestigious journals such as New England Journal of Medicine, The EMBO Journal and Gastroenterology.

In The Last Decade

Daniel S. Pratt

52 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evaluation of Abnormal Liver-Enzyme Results in Asymptomatic Patients

2000 839 citations Daniel S. Pratt, Marshall M. Kaplan New England Journal of Medicine profile →
Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID‐19 Pandemic: AASLD Expert Panel Consensus Statement

2020 338 citations Oren K. Fix, Daniel S. Pratt et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel S. Pratt United States	22	1.3k	1.3k	915	433	371	55	2.8k
Kwan Soo Byun South Korea	31	1.9k 1.4×	1.9k 1.5×	680 0.7×	268 0.6×	314 0.8×	200	3.3k
Athanasios J. Archimandritis Greece	36	1.9k 1.4×	1.3k 1.0×	884 1.0×	177 0.4×	170 0.5×	134	3.3k
Tobias Goeser Germany	26	2.6k 2.0×	2.3k 1.8×	596 0.7×	287 0.7×	456 1.2×	141	4.1k
Kevork Peltekian Canada	28	1.7k 1.3×	1.9k 1.5×	1.1k 1.1×	286 0.7×	151 0.4×	78	3.2k
Anna Licata Italy	35	2.0k 1.5×	1.6k 1.3×	743 0.8×	486 1.1×	106 0.3×	159	4.1k
P. Michielsen Belgium	34	2.1k 1.6×	1.5k 1.2×	662 0.7×	253 0.6×	150 0.4×	219	4.0k
M. Angélico Italy	37	2.3k 1.8×	2.5k 2.0×	1.4k 1.5×	884 2.0×	225 0.6×	228	4.4k
Georges‐Philippe Pageaux France	40	2.4k 1.9×	2.9k 2.3×	1.3k 1.4×	422 1.0×	210 0.6×	178	4.6k
Paul Gow Australia	31	1.9k 1.4×	2.2k 1.7×	945 1.0×	165 0.4×	132 0.4×	173	3.9k
Dominique Debray France	37	1.2k 0.9×	1.6k 1.2×	1.8k 2.0×	447 1.0×	273 0.7×	149	4.2k

Countries citing papers authored by Daniel S. Pratt

Since Specialization

Citations

This map shows the geographic impact of Daniel S. Pratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel S. Pratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel S. Pratt more than expected).

Fields of papers citing papers by Daniel S. Pratt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel S. Pratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel S. Pratt. The network helps show where Daniel S. Pratt may publish in the future.

Co-authorship network of co-authors of Daniel S. Pratt

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel S. Pratt. A scholar is included among the top collaborators of Daniel S. Pratt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel S. Pratt. Daniel S. Pratt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rahman, Raza‐Ur, et al.. (2023). Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease. The EMBO Journal. 42(24). e113898–e113898. 18 indexed citations

Pratt, Henry, et al.. (2023). Beyond genome-wide association studies: Investigating the role of noncoding regulatory elements in primary sclerosing cholangitis. Hepatology Communications. 7(10). 3 indexed citations

Schattenberg, Jörn M., Albert Parés, Kris V. Kowdley, et al.. (2021). A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA. Journal of Hepatology. 74(6). 1344–1354. 125 indexed citations

Bloom, Patricia P., Trisha S. Pasricha, Karin L. Andersson, et al.. (2020). Hepatology Consultants Often Disagree on Etiology of Abnormal Liver Biochemistries in COVID-19 but Agree on Management. Digestive Diseases and Sciences. 66(6). 1852–1854. 2 indexed citations

Allegretti, Jessica R., Zain Kassam, Madeline Carrellas, et al.. (2019). Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial. The American Journal of Gastroenterology. 114(7). 1071–1079. 166 indexed citations

Allegretti, Andrew S., Darrick K. Li, Harish Seethapathy, et al.. (2019). Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placement. PLoS ONE. 14(5). e0217442–e0217442. 22 indexed citations

Allegretti, Jessica R., Benjamin H. Mullish, Zain Kassam, et al.. (2018). Bile Acid Profiles are Not Altered by Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis: Category Award (Liver): Presidential Poster Award. The American Journal of Gastroenterology. 113(Supplement). S574–S576. 1 indexed citations

Allegretti, Jessica R., Zain Kassam, Madeline Carrellas, et al.. (2018). Tu1511 - Microbial Engraftment Correlates with a Decrease in Alkaline Phosphatase (Alp) after Fecal Microbiota Transplantation from a Rationally-Selected Donor in Primary Sclerosing Cholangitis. Gastroenterology. 154(6). S–948. 1 indexed citations

Pratt, Daniel S. & Lindsay Y. King. (2015). Primary Biliary Cirrhosis.

10.

Johncilla, Melanie, Joseph Misdraji, Daniel S. Pratt, et al.. (2015). Ipilimumab-associated Hepatitis. The American Journal of Surgical Pathology. 39(8). 1075–1084. 158 indexed citations

11.

Corey, Kathleen E. & Daniel S. Pratt. (2009). Review: Current status of therapy for hepatocellular carcinoma. Therapeutic Advances in Gastroenterology. 2(1). 45–57. 15 indexed citations

12.

McGovern, Barbara, Yoav Golan, Maria J Lopez, et al.. (2007). The Impact of Cirrhosis on CD4+ T Cell Counts in HIV-Seronegative Patients. Clinical Infectious Diseases. 44(3). 431–437. 99 indexed citations

13.

Fix, Oren K., et al.. (2006). Obscure Gastrointestinal Hemorrhage from Mesenteric Varices Diagnosed by Video Capsule Endoscopy. Digestive Diseases and Sciences. 51(7). 1169–1174. 9 indexed citations

14.

Rutherford, Anna & Daniel S. Pratt. (2006). Cholestasis and cholestatic syndromes. Current Opinion in Gastroenterology. 22(3). 209–214. 15 indexed citations

15.

Pratt, Daniel S., et al.. (2005). Heterozygous Alpha1-Antitrypsin Deficiency and Chronic Hepatitis C. Clinical Gastroenterology and Hepatology. 3(10). A29–A29. 2 indexed citations

16.

Pratt, Daniel S., et al.. (2001). LIVING-DONOR VERSUS CADAVERIC LIVER TRANSPLANTATION FOR NON-RESECTABLE SMALL HEPATOCELLULAR CARCINOMA AND COMPENSATED CIRRHOSIS: A DECISION ANALYSIS1. Transplantation. 72(5). 861–868. 88 indexed citations

17.

Pratt, Daniel S. & Scott K. Epstein. (2000). Recent Advances in Critical Care Gastroenterology. American Journal of Respiratory and Critical Care Medicine. 161(5). 1417–1420. 5 indexed citations

18.

Pratt, Daniel S. & Marshall M. Kaplan. (2000). Evaluation of Abnormal Liver-Enzyme Results in Asymptomatic Patients. New England Journal of Medicine. 342(17). 1266–1271. 839 indexed citations breakdown →

19.

Pedrosa, Marcos, et al.. (1997). Utility of hepatic iron index in American patients with hereditary hemochromatosis: A multicenter study. Gastroenterology. 113(4). 1270–1277. 50 indexed citations

20.

Gibb, I, et al.. (1986). Immunological and colorimetric determination of prostatic acid phosphatase--technical and clinical reappraisal in symptomatic patients.. Clinical Chemistry. 32(9). 1760–1766. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact